Predictors of variability in urinary incontinence and overactive bladder symptoms

Neurourology and Urodynamics

Volumn 29, Issue 3, 2010, Pages 328-335

  Stewart, W F ^a   Minassian, V A ^a   Hirsch, A G ^a   Kolodner, K ^a   Fitzgerald, M ^b   Burgio, K ^c   Cundiff, G W ^d   Blaivas, J ^e   Newman, D ^f   Lerch, V R ^a   Dilley, A ^g  

^a GEISINGER HEALTH SYSTEM   (United States)

^b LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

^c UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g GLAXOSMITHKLINE   (United States)

Author keywords

Epidemiology; Incontinence; Longitudinal; Urgency

Indexed keywords

ADULT; AGED; ARTICLE; DISEASE DURATION; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OVERACTIVE BLADDER; PREDICTION; PRIMARY HEALTH CARE; RECALL; SCORING SYSTEM; SYMPTOM; URINARY URGENCY; URINE INCONTINENCE; CROSS-SECTIONAL STUDY; LONGITUDINAL STUDY; MIDDLE AGED; QUESTIONNAIRE;

AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; QUESTIONNAIRES; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE;

EID: 77953604443     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.20753     Document Type: Article

References (27)

1. Thomas TM, Plymat KR, Blannin J, et al. Prevalence of urinary incontinence. Br Med J 1980;281:1243-1245
2. Hannestad YS, Rortveit G, Sandvik H, et al. Norwegian EPINCONT study. A community-based epidemiological survey of female urinary incontinence: The Norwegian EPINCONT study. Epidemiology of incontinence in the County of Nord-Trondelag. J Clin Epidemiol 2000;53:1150-1157
3. Thom D. Variation in estimates of urinary incontinence prevalence in the community: Effects of differences in definition, population characteristics, and study type. J Am Geriatr Soc 1998;46:473-480
4. Yarnell JW, Voyle GJ, Richards CJ, et al. The prevalence and severity of urinary incontinence in women. J Epidemiol Community Health 1981;35:71-74
5. Milsom I. The prevalence of urinary incontinence. Acta Obstet Gynecol Scand 2000;79:1056-1059
6. Herzog AR, Fultz NH. Prevalence and incidence of urinary incontinence in community-dwelling populations. J Am Geriatr Soc 1990;38:273-281
7. Lukacz ES, Lawrence JM, Contreras R, et al. Parity, mode of delivery, and pelvic floor disorders. Obstet Gynecol 2006;107:1253-1260
8. Melville JL, Katon W, Delaney K, et al. Urinary incontinence in US women: A population-based study. Arch Intern Med 2005;165:537-542
9. Hunskaar S, Burgio K, Diokno A, et al. Epidemiology and natural history of urinary incontinence in women. Urology 2003;62:16-23. (Pubitemid 41116578)
10. Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003;20:327-336
11. StewartWF, Lipton RB, Celentano DD, et al. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. J Am Med Assoc 1992;267:64-69
12. Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:617-627 (Pubitemid 40973437)
13. Moorman JE, Rudd RA, Johnson CA, et al. Centers for Disease Control and Prevention (CDC). National surveillance for asthma-United States, 19802004. Morb Mortal Wkly Rep Surveil Summ 2007;56:1-54.
14. Moayyedi P, Axon AT. Review article: Gastro-oesophageal reflux disease- The extent of the problem. Aliment Pharmacol Ther 2005;22:11-19
15. Stewart WF, Wood GC, Razzaghi H, et al. Work impact of migraine. J Occup Environ Med 2008;50:736-745.
16. Bigal ME, Serrano D, Buse D, et al. Acute migraine medications and evolution from episodic to chronic migraine: A longitudinal population-based study. Headache 2008;48:1157-1168
17. Minassian VA, Stewart WF, Hirsch AG. Why do stress and urge incontinence co-occur much more often than expected? Int Urogynecol J Pelvic Floor Dysfunct 2008;19:1429-1440
18. Herzog AR, Diokno AC, Brown MB, et al. Two-year incidence, remission, and change patterns of urinary incontinence in noninstitutionalized older adults. J Gerontol 1990;45:M67-74.
19. Sandvik H, Seim A, Vanvik A, et al. A severity index for epidemiological surveys of female urinary incontinence: Comparison with 48-hour padweighing tests. Neurourol Urodyn 2000;19:137-145
20. Gibson PJ, Koepsell TD, Diehr P, et al. Increasing response rates for mailed surveys of medicaid clients and other low-income populations. Am J Epidemiol 1999;149:1057-1062
21. Scher AI, Stewart WF, Liberman J, et al. Prevalence of frequent headache in a population sample. Headache 1998;38:497-506.
22. Moller LA, Lose G, Jorgensen T. Incidence and remission rates of lower urinary tract symptoms at one year in women aged 40-60: Longitudinal study. Br Med J 2000;320:1429-1432
23. Nygaard IE, Lemke JH. Urinary incontinence in rural older women: Prevalence, incidence and remission. J Am Geriatr Soc 1996;44:1049-1054
24. D'Souza AO, Smith MJ, Miller LA, et al. Persistence, adherence, and switch rates among extended-release and immediate-release overactive bladder medications in a regional managed care plan. J Manag Care Pharm 2008;14: 291-301.
25. Yu YF, Nichol MB, Yu AP, et al. Persistence and adherence of medications for chronic overactive bladder/urinary incontinence in the California Medicaid Program. Value Health 2005;8:495-505.
26. Lawrence M, Guay DR, Benson SR, et al. Immediate-release oxybutynin versus tolterodine in detrusor overactivity: A population analysis. Pharmacotherapy 2000;20:470-475
27. van Leeuwen JH, Castro R, Busse M, et al. The placebo effect in the pharmacologic treatment of patients with lower urinary tract symptoms. Eur Urol 2006;50:440-452 (discussion 453).